Anzeige
Mehr »
Montag, 20.04.2026 - Börsentäglich über 12.000 News
China - das Pentagon - und dieses Unternehmen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrJennifer McClellan makes significant sale in Verizon Communications stock
FrSheri Biggs from SC03 invests in Apollo Debt Solutions and iShares Bitcoin Trust ETF
FrGenmab completes share capital reduction of 1.9 million shares
FrAnthropic launches Claude Design for visual work
FrUBS reiterates Buy on Gildan Activewear stock, keeps $110 target
FrFifth Third Q1 2026 slides: Comerica deal lifts NIM to 3.30%
FrNextEnergy Solar Fund estimates NAV impact from UK carbon tax removal
FrDish TV India shareholders approve three independent directors
FrUBS reiterates Procter & Gamble stock rating on earnings outlook
FrUlta Beauty stock price target reaffirmed at $810 by UBS
FrUBS reiterates Buy on Keurig Dr Pepper stock ahead of earnings
FrUBS cuts Vail Resorts stock price target on weather challenges
FrUBS cuts Philip Morris stock price target on ZYN volume concerns
FrUBS raises APA stock price target to $45 on Egypt growth outlook
FrBrinker stock maintains Buy rating at UBS on chicken sandwich launch
FrPeter Gyllenhammar increases stake in DCI Advisors to 8.62%
FrTruist raises Bank of New York Mellon stock price target on fees
FrTruist reiterates Eli Lilly stock rating on positive trial data
FrTruist cuts U.S. Bancorp stock price target to $62 on NIM outlook
FrUBS reiterates Buy on Summit Therapeutics stock ahead of trial data
FrJefferies raises Vale stock price target to $21 on production beat
FrPiper Sandler cuts ICU Medical stock price target on freight costs
FrTruist raises Citizens Financial stock price target on earnings path
FrPiper Sandler cuts Merit Medical stock price target on model update
FrPiper Sandler cuts Abbott Labs stock price target on weak diabetes sales